BreastCancer.org partners with HealthCentral

Share this article:
BreastCancer.org partners with HealthCentral
BreastCancer.org partners with HealthCentral

BreastCancer.org opened the door for banner advertising and tapped online health network HealthCentral for the development of sponsorship programs, according to an announcement today.

Jeremy Shane, president and COO of HealthCentral, said the collaboration includes the provision of awareness banners, links to sponsored microsites outside of BreastCancer.org, and an aggregation of content from the site to be distributed elsewhere within HealthCentral's network. Shane noted that HealthCentral will work alongside BreastCancer.org's internal traffic drivers to redirect users to relevant sponsored content as well. 

Sponsorship opportunities will focus on breast cancer-related treatments and products, as well as peripheral conditions associated with the disease and treatment, such as osteoporosis, anemia, nausea, sleep disorders, depression and diabetes.

BreastCancer.org is currently positioned at the very top of Google's organic search results for the phrases "breast cancer" and "breast cancer treatment." The site provides copious amounts of information—as well as interactive forums for discussion—on numerous topics related to the disease.

Regarding the forum discussions on the site, Shane said HealthCentral will seek the organization's council for appropriate advertising possibilities. "Initially, there will be no pharmaceutical ads in this space," said Shane.

A letter posted on BreastCancer.org on April 29, signed by organization executives Marisa Weiss and Hope Wohl, outlined the need for industry support in tough economic times. “Since our inception, we have depended on contributions from individuals and corporations…unfortunately, that has become more challenging for us,” the letter said. The site will now accept banners from paid sponsors, as specified by the site's sponsorship guidelines, according to the letter. There will be certain limitations on the kinds of campaigns executed on the site, said Shane, due to BreastCancer.org's status as a nonprofit organization. 

Even so, HealthCentral's partnership with an organization like BreastCancer.org is appealing to marketers, in that it "conveys a seriousness...and positions a brand on the side of the patient," said Shane, adding that it also enables marketers to reach patients at "particular stages in their health trajectories."

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...